Similar to our study, Long et al. [43] observed that increases in memory B cells and HLA-DR on plasmacytoid dendritic cells may enhance susceptibility to OM, while decreased frequencies of CD62L monocytes and CD86 plasmacytoid dendritic cells were linked to a reduced risk of OM. This evidence concerns the gene SELL and ocular melanoma.